- Previous Close
0.0208 - Open
0.0208 - Bid 0.0401 x 900
- Ask 0.4000 x 800
- Day's Range
0.0208 - 0.0208 - 52 Week Range
0.0001 - 0.9656 - Volume
9 - Avg. Volume
166 - Market Cap (intraday)
681 - Beta (5Y Monthly) 3.71
- PE Ratio (TTM)
-- - EPS (TTM)
-10.6600 - Earnings Date Apr 3, 2025 - Apr 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
ampiopharma.comRecent News: AMPE
View MorePerformance Overview: AMPE
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMPE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMPE
View MoreValuation Measures
Market Cap
681.00
Enterprise Value
-3.81M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.00
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.57%
Return on Equity (ttm)
-113.96%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
-10.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
4.12M
Total Debt/Equity (mrq)
13.42%
Levered Free Cash Flow (ttm)
-5.37M